vs
IONIS PHARMACEUTICALS INC（IONS）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
IONIS PHARMACEUTICALS INC的季度营收约是STURM RUGER & CO INC的1.3倍（$203.3M vs $151.1M），STURM RUGER & CO INC同比增速更快（3.6% vs -10.3%），STURM RUGER & CO INC自由现金流更多（$12.3M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 5.1%）
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
IONS vs RGR — 直观对比
营收规模更大
IONS
是对方的1.3倍
$151.1M
营收增速更快
RGR
高出13.9%
-10.3%
自由现金流更多
RGR
多$171.3M
$-159.0M
两年增速更快
IONS
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $203.3M | $151.1M |
| 净利润 | $-229.4M | — |
| 毛利率 | 96.1% | 17.8% |
| 营业利润率 | -105.5% | 2.3% |
| 净利率 | -112.8% | — |
| 营收同比 | -10.3% | 3.6% |
| 净利润同比 | -119.8% | — |
| 每股收益（稀释后） | $-1.35 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IONSRGR
| Q4 25 | $203.3M | $151.1M | ||
| Q3 25 | $156.7M | $126.8M | ||
| Q2 25 | $452.0M | $132.5M | ||
| Q1 25 | $131.6M | $135.7M | ||
| Q4 24 | $226.6M | $145.8M | ||
| Q3 24 | $133.8M | $122.3M | ||
| Q2 24 | $225.3M | $130.8M | ||
| Q1 24 | $119.5M | $136.8M |
净利润IONSRGR
| Q4 25 | $-229.4M | — | ||
| Q3 25 | $-128.6M | $1.6M | ||
| Q2 25 | $123.6M | $-17.2M | ||
| Q1 25 | $-146.9M | $7.8M | ||
| Q4 24 | $-104.3M | — | ||
| Q3 24 | $-140.5M | $4.7M | ||
| Q2 24 | $-66.3M | $8.3M | ||
| Q1 24 | $-142.8M | $7.1M |
毛利率IONSRGR
| Q4 25 | 96.1% | 17.8% | ||
| Q3 25 | 98.5% | 15.1% | ||
| Q2 25 | 99.1% | 3.9% | ||
| Q1 25 | 98.9% | 22.0% | ||
| Q4 24 | 98.3% | 22.8% | ||
| Q3 24 | 99.2% | 18.5% | ||
| Q2 24 | 98.2% | 22.3% | ||
| Q1 24 | 98.2% | 21.5% |
营业利润率IONSRGR
| Q4 25 | -105.5% | 2.3% | ||
| Q3 25 | -102.2% | -2.7% | ||
| Q2 25 | 30.9% | -15.6% | ||
| Q1 25 | -111.6% | 6.2% | ||
| Q4 24 | -48.9% | 7.8% | ||
| Q3 24 | -111.1% | 3.1% | ||
| Q2 24 | -29.3% | 6.9% | ||
| Q1 24 | -125.1% | 5.5% |
净利率IONSRGR
| Q4 25 | -112.8% | — | ||
| Q3 25 | -82.1% | 1.2% | ||
| Q2 25 | 27.3% | -13.0% | ||
| Q1 25 | -111.6% | 5.7% | ||
| Q4 24 | -46.1% | — | ||
| Q3 24 | -105.0% | 3.9% | ||
| Q2 24 | -29.4% | 6.3% | ||
| Q1 24 | -119.5% | 5.2% |
每股收益（稀释后）IONSRGR
| Q4 25 | $-1.35 | $0.22 | ||
| Q3 25 | $-0.80 | $0.10 | ||
| Q2 25 | $0.70 | $-1.05 | ||
| Q1 25 | $-0.93 | $0.46 | ||
| Q4 24 | $-0.66 | $0.62 | ||
| Q3 24 | $-0.95 | $0.28 | ||
| Q2 24 | $-0.45 | $0.47 | ||
| Q1 24 | $-0.98 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | $92.5M |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $489.1M | $283.8M |
| 总资产 | $3.5B | $342.0M |
| 负债/权益比越低杠杆越低 | 3.71× | — |
8季度趋势，按日历期对齐
现金及短期投资IONSRGR
| Q4 25 | $2.7B | $92.5M | ||
| Q3 25 | $2.2B | $80.8M | ||
| Q2 25 | $2.3B | $101.4M | ||
| Q1 25 | $2.1B | $108.3M | ||
| Q4 24 | $2.3B | $105.5M | ||
| Q3 24 | $2.5B | $96.0M | ||
| Q2 24 | $2.1B | $105.6M | ||
| Q1 24 | $2.2B | $115.3M |
总债务IONSRGR
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IONSRGR
| Q4 25 | $489.1M | $283.8M | ||
| Q3 25 | $618.0M | $279.6M | ||
| Q2 25 | $631.7M | $289.3M | ||
| Q1 25 | $475.7M | $321.5M | ||
| Q4 24 | $588.4M | $319.6M | ||
| Q3 24 | $662.5M | $314.9M | ||
| Q2 24 | $263.7M | $321.5M | ||
| Q1 24 | $296.5M | $332.0M |
总资产IONSRGR
| Q4 25 | $3.5B | $342.0M | ||
| Q3 25 | $3.0B | $342.3M | ||
| Q2 25 | $3.0B | $349.5M | ||
| Q1 25 | $2.8B | $379.0M | ||
| Q4 24 | $3.0B | $384.0M | ||
| Q3 24 | $3.1B | $373.5M | ||
| Q2 24 | $2.7B | $376.7M | ||
| Q1 24 | $2.8B | $385.0M |
负债/权益比IONSRGR
| Q4 25 | 3.71× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.13× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-137.7M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $-159.0M | $12.3M |
| 自由现金流率自由现金流/营收 | -78.2% | 8.2% |
| 资本支出强度资本支出/营收 | 10.5% | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-320.0M | $38.5M |
8季度趋势，按日历期对齐
经营现金流IONSRGR
| Q4 25 | $-137.7M | $15.5M | ||
| Q3 25 | $-131.4M | $12.9M | ||
| Q2 25 | $151.3M | $14.7M | ||
| Q1 25 | $-150.8M | $11.1M | ||
| Q4 24 | $-116.1M | $20.0M | ||
| Q3 24 | $-115.0M | $9.4M | ||
| Q2 24 | $-119.9M | $18.7M | ||
| Q1 24 | $-149.9M | $7.3M |
自由现金流IONSRGR
| Q4 25 | $-159.0M | $12.3M | ||
| Q3 25 | $-136.7M | $7.0M | ||
| Q2 25 | $139.0M | $9.1M | ||
| Q1 25 | $-163.4M | $10.0M | ||
| Q4 24 | $-141.6M | $16.4M | ||
| Q3 24 | $-124.0M | $2.6M | ||
| Q2 24 | $-126.1M | $10.1M | ||
| Q1 24 | $-154.4M | $5.6M |
自由现金流率IONSRGR
| Q4 25 | -78.2% | 8.2% | ||
| Q3 25 | -87.2% | 5.5% | ||
| Q2 25 | 30.8% | 6.9% | ||
| Q1 25 | -124.1% | 7.4% | ||
| Q4 24 | -62.5% | 11.2% | ||
| Q3 24 | -92.7% | 2.1% | ||
| Q2 24 | -56.0% | 7.7% | ||
| Q1 24 | -129.2% | 4.1% |
资本支出强度IONSRGR
| Q4 25 | 10.5% | 2.1% | ||
| Q3 25 | 3.4% | 4.6% | ||
| Q2 25 | 2.7% | 4.2% | ||
| Q1 25 | 9.6% | 0.8% | ||
| Q4 24 | 11.3% | 2.5% | ||
| Q3 24 | 6.8% | 5.5% | ||
| Q2 24 | 2.8% | 6.6% | ||
| Q1 24 | 3.8% | 1.3% |
现金转化率IONSRGR
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
